ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.805
      0.02%
      Bitcoin
      64,835.99
      -0.46%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Idera Pharmaceuticals Inc (IDRA)

      7. Idera Pharmaceuticals Inc (IDRA) News

      IDRA

      Idera Pharmaceuticals (IDRA)

      Idera Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDRA
      DateTimeSourceHeadlineSymbolCompany
      09/28/20225:01PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/28/20224:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/28/20224:09PMGlobeNewswire Inc.Idera Pharmaceuticals Acquires AceragenNASDAQ:IDRAIdera Pharmaceuticals Inc
      08/09/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      08/09/20224:15PMGlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
      08/09/20224:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/07/20225:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/07/20225:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/06/20225:19PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
      07/01/20226:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/27/20224:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/24/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/27/20224:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/17/20228:04AMGlobeNewswire Inc.Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCNASDAQ:IDRAIdera Pharmaceuticals Inc
      05/05/20224:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/05/20224:15PMGlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
      04/29/20224:16PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/05/20225:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/04/20225:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/04/20225:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/04/20225:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/04/20225:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/31/20224:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/31/20224:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/31/20224:15PMGlobeNewswire Inc.Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IDRA